Anders Blanck News Today

According to a compilation from the Swedish Medicines Agency, the number of residually notified medicines increased by 54 % in Sweden last year compared to the previous year. In a bill presented by the government a number of proposals are put forward to counteract the problem.

Anders Blanck, vd för branschorganisationen Lif – de forskande läkemedelsföretagen, anser att regionerna måste inse att nationell samordning är nödvändig.

Anders Blanck, CEO of Lif, the trade association for the research-based Swedish pharmaceutical industry, writes about the challenges the world faces from...